ArticleAesthetic surgery journal. Open forum2025
The Patient Voice in Aesthetic Medicine: Findings From a Global Survey of Cosmetic Neurotoxin Patients.
Article in Aesthetic surgery journal. Open forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Proposal for a Multidimensional Scale to Measure Trust Between Physician and Patient in the Aesthetic Surgery Sector.Aesthetic plastic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patient satisfaction following cosmetic neurotoxin treatment has been widely studied, but little is known about how this affects downstream behavior. Objectives: To investigate the actions taken by patients following cosmetic neurotoxin injection, with regard to their most and least positive treatment experiences. Methods: This was an online, self-administered survey conducted among adults residing in Brazil, Canada, United Kingdom, and United States. Eligible participants had received 4 or more previous neurotoxin treatments to temporarily improve the appearance of upper facial lines, at least one of which was in the past 12 months. Results: A total of 1612 respondents completed the questionnaire (61% female; mean age: 38.1 ± 9.6 years). After their most positive experience, 81% said they engaged in actions directed toward their healthcare professional (HCP) (eg, scheduled another treatment or posted a review on the HCP's website), and 81% took actions directed at others (eg, talked to friends and family or posted a review online). After their least positive experience, 58% engaged in actions directed toward their HCP (with 22% expressing dissatisfaction directly), and 73% took actions to inform other people; many said they discouraged others from using their HCP (52%) or from seeking cosmetic neurotoxin injections altogether (27%). Conclusions: Respondents were less likely to inform their HCP of their satisfaction level after their least positive experience of cosmetic neurotoxin treatment compared with the most positive. Thus, practitioners may often be unaware of dissatisfied individuals. Patient-centered care and consistent proactive follow-up are essential to understanding patient perspectives on outcomes. Level of Evidence: 5 (Therapeutic).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.